Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tomography, Optical Coherence | 46 | 2022 | 2954 | 7.080 |
Why?
|
Fluorescein Angiography | 30 | 2022 | 1086 | 5.970 |
Why?
|
Retinal Vessels | 18 | 2022 | 863 | 4.710 |
Why?
|
Choroid | 8 | 2022 | 364 | 3.210 |
Why?
|
Retinal Diseases | 9 | 2021 | 709 | 2.550 |
Why?
|
Diabetic Retinopathy | 7 | 2021 | 1300 | 2.430 |
Why?
|
Visual Acuity | 21 | 2022 | 2714 | 1.860 |
Why?
|
Retinal Telangiectasis | 3 | 2019 | 26 | 1.780 |
Why?
|
Optic Disk | 7 | 2020 | 421 | 1.760 |
Why?
|
Macular Degeneration | 12 | 2021 | 1015 | 1.710 |
Why?
|
Vitrectomy | 4 | 2021 | 392 | 1.530 |
Why?
|
Choroid Diseases | 4 | 2022 | 63 | 1.500 |
Why?
|
Retinal Artery | 4 | 2021 | 109 | 1.500 |
Why?
|
Retinal Vein Occlusion | 4 | 2021 | 149 | 1.460 |
Why?
|
Ciliary Arteries | 3 | 2019 | 19 | 1.360 |
Why?
|
Wet Macular Degeneration | 5 | 2019 | 165 | 1.350 |
Why?
|
Retina | 9 | 2021 | 2659 | 1.320 |
Why?
|
Retinal Detachment | 3 | 2020 | 429 | 1.280 |
Why?
|
Scleral Buckling | 2 | 2020 | 95 | 1.230 |
Why?
|
Myopia | 2 | 2021 | 254 | 1.220 |
Why?
|
Retinal Neovascularization | 3 | 2021 | 287 | 1.210 |
Why?
|
Fundus Oculi | 9 | 2021 | 560 | 1.100 |
Why?
|
Fovea Centralis | 3 | 2022 | 126 | 1.030 |
Why?
|
Retinal Perforations | 3 | 2016 | 138 | 1.010 |
Why?
|
Macular Edema | 2 | 2021 | 387 | 0.970 |
Why?
|
Ophthalmology | 3 | 2021 | 560 | 0.930 |
Why?
|
Vision Disorders | 4 | 2022 | 1090 | 0.920 |
Why?
|
Scotoma | 3 | 2020 | 128 | 0.900 |
Why?
|
Visual Field Tests | 5 | 2019 | 415 | 0.830 |
Why?
|
Macula Lutea | 2 | 2021 | 180 | 0.820 |
Why?
|
Retinal Hemorrhage | 3 | 2021 | 98 | 0.790 |
Why?
|
Central Serous Chorioretinopathy | 1 | 2022 | 32 | 0.770 |
Why?
|
Retinal Vein | 1 | 2021 | 46 | 0.730 |
Why?
|
Vitreous Hemorrhage | 1 | 2021 | 47 | 0.720 |
Why?
|
Geographic Atrophy | 2 | 2019 | 92 | 0.720 |
Why?
|
Uveomeningoencephalitic Syndrome | 1 | 2020 | 22 | 0.700 |
Why?
|
Visual Fields | 6 | 2019 | 1063 | 0.700 |
Why?
|
Optic Neuropathy, Ischemic | 2 | 2018 | 87 | 0.690 |
Why?
|
Microvessels | 5 | 2022 | 585 | 0.670 |
Why?
|
Presenilin-1 | 2 | 2021 | 665 | 0.670 |
Why?
|
Vitreoretinal Surgery | 1 | 2019 | 28 | 0.650 |
Why?
|
Eye Diseases, Hereditary | 1 | 2020 | 124 | 0.650 |
Why?
|
Artificial Intelligence | 4 | 2021 | 2666 | 0.640 |
Why?
|
Vision, Ocular | 2 | 2022 | 457 | 0.630 |
Why?
|
Retinal Drusen | 3 | 2021 | 78 | 0.630 |
Why?
|
Dark Adaptation | 5 | 2021 | 224 | 0.630 |
Why?
|
von Hippel-Lindau Disease | 1 | 2020 | 154 | 0.620 |
Why?
|
Exudates and Transudates | 1 | 2019 | 175 | 0.610 |
Why?
|
Diagnostic Techniques, Ophthalmological | 3 | 2019 | 252 | 0.610 |
Why?
|
Laser Coagulation | 1 | 2020 | 335 | 0.600 |
Why?
|
Eye Injuries | 3 | 2016 | 228 | 0.600 |
Why?
|
Polyhydroxyethyl Methacrylate | 1 | 2017 | 30 | 0.590 |
Why?
|
Giant Cell Arteritis | 2 | 2022 | 307 | 0.570 |
Why?
|
Chorioretinitis | 1 | 2017 | 43 | 0.570 |
Why?
|
Access to Information | 1 | 2020 | 317 | 0.560 |
Why?
|
Retinitis Pigmentosa | 1 | 2020 | 395 | 0.540 |
Why?
|
Optic Atrophy, Hereditary, Leber | 1 | 2016 | 50 | 0.520 |
Why?
|
Blindness | 1 | 2020 | 585 | 0.520 |
Why?
|
Emulsions | 2 | 2020 | 150 | 0.500 |
Why?
|
Prosthesis Implantation | 3 | 2022 | 594 | 0.490 |
Why?
|
Contrast Sensitivity | 3 | 2022 | 253 | 0.490 |
Why?
|
Angiography | 3 | 2022 | 1597 | 0.480 |
Why?
|
Silicone Oils | 1 | 2014 | 22 | 0.470 |
Why?
|
Optic Disk Drusen | 3 | 2021 | 38 | 0.470 |
Why?
|
Endotamponade | 1 | 2014 | 37 | 0.460 |
Why?
|
Prospective Studies | 19 | 2021 | 54886 | 0.450 |
Why?
|
Cross-Sectional Studies | 19 | 2022 | 26325 | 0.450 |
Why?
|
Regional Blood Flow | 1 | 2017 | 1479 | 0.440 |
Why?
|
Choroidal Neovascularization | 1 | 2017 | 364 | 0.440 |
Why?
|
Cataract Extraction | 1 | 2017 | 464 | 0.430 |
Why?
|
Diabetes Mellitus | 2 | 2021 | 5886 | 0.400 |
Why?
|
Prostheses and Implants | 2 | 2022 | 1275 | 0.390 |
Why?
|
Humans | 75 | 2022 | 767040 | 0.380 |
Why?
|
Surgery, Computer-Assisted | 1 | 2019 | 996 | 0.380 |
Why?
|
Photography | 3 | 2021 | 536 | 0.320 |
Why?
|
Metabolomics | 4 | 2019 | 1675 | 0.310 |
Why?
|
Middle Aged | 33 | 2022 | 223233 | 0.300 |
Why?
|
Pilot Projects | 1 | 2021 | 8732 | 0.290 |
Why?
|
Follow-Up Studies | 10 | 2021 | 39317 | 0.290 |
Why?
|
Female | 38 | 2022 | 396660 | 0.240 |
Why?
|
Male | 38 | 2022 | 364203 | 0.240 |
Why?
|
Postoperative Complications | 2 | 2017 | 15824 | 0.240 |
Why?
|
Biomedical Research | 1 | 2020 | 3464 | 0.240 |
Why?
|
Aged | 26 | 2021 | 171319 | 0.230 |
Why?
|
Corneal Diseases | 2 | 2022 | 535 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3112 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3234 | 0.200 |
Why?
|
Aged, 80 and over | 13 | 2020 | 59548 | 0.200 |
Why?
|
Retrospective Studies | 14 | 2022 | 81659 | 0.200 |
Why?
|
Alzheimer Disease | 2 | 2021 | 8717 | 0.200 |
Why?
|
Hypertension | 1 | 2022 | 8615 | 0.200 |
Why?
|
Adult | 18 | 2022 | 223317 | 0.190 |
Why?
|
Imaging, Three-Dimensional | 4 | 2019 | 4052 | 0.190 |
Why?
|
Intravitreal Injections | 3 | 2019 | 402 | 0.180 |
Why?
|
Glaucoma, Open-Angle | 2 | 2018 | 742 | 0.170 |
Why?
|
Muscle Spasticity | 1 | 2021 | 159 | 0.170 |
Why?
|
Pandemics | 1 | 2020 | 8736 | 0.170 |
Why?
|
Spinocerebellar Ataxias | 1 | 2021 | 108 | 0.170 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2021 | 204 | 0.170 |
Why?
|
Electroretinography | 2 | 2020 | 524 | 0.170 |
Why?
|
Vitreoretinopathy, Proliferative | 1 | 2020 | 75 | 0.170 |
Why?
|
Colombia | 1 | 2021 | 287 | 0.170 |
Why?
|
Algorithms | 4 | 2021 | 14098 | 0.170 |
Why?
|
Glaucoma Drainage Implants | 1 | 2021 | 107 | 0.170 |
Why?
|
Papilledema | 1 | 2021 | 130 | 0.170 |
Why?
|
Intraocular Pressure | 3 | 2021 | 1304 | 0.160 |
Why?
|
Apolipoprotein E3 | 1 | 2019 | 105 | 0.160 |
Why?
|
Sclera | 1 | 2020 | 189 | 0.160 |
Why?
|
Glaucoma | 2 | 2022 | 1194 | 0.160 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2020 | 190 | 0.160 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2020 | 355 | 0.150 |
Why?
|
Intraoperative Period | 1 | 2019 | 512 | 0.150 |
Why?
|
Body Fluids | 1 | 2019 | 321 | 0.140 |
Why?
|
Nerve Fibers | 2 | 2017 | 706 | 0.140 |
Why?
|
Mutation | 2 | 2021 | 30211 | 0.140 |
Why?
|
Indocyanine Green | 1 | 2019 | 237 | 0.140 |
Why?
|
Retinal Pigment Epithelium | 2 | 2018 | 309 | 0.140 |
Why?
|
Capillaries | 2 | 2017 | 755 | 0.140 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2020 | 541 | 0.140 |
Why?
|
Vitreous Detachment | 1 | 2016 | 23 | 0.140 |
Why?
|
Fibrinolysin | 1 | 2016 | 130 | 0.130 |
Why?
|
Arterioles | 1 | 2017 | 252 | 0.130 |
Why?
|
Retinal Artery Occlusion | 1 | 2017 | 83 | 0.130 |
Why?
|
Coloring Agents | 1 | 2019 | 565 | 0.130 |
Why?
|
Angiogenesis Inhibitors | 2 | 2019 | 2055 | 0.130 |
Why?
|
Dilatation, Pathologic | 1 | 2017 | 527 | 0.130 |
Why?
|
Early Diagnosis | 1 | 2021 | 1188 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 754 | 0.130 |
Why?
|
Case-Control Studies | 4 | 2021 | 22254 | 0.120 |
Why?
|
Lyme Disease | 1 | 2021 | 627 | 0.120 |
Why?
|
Retinal Ganglion Cells | 2 | 2017 | 810 | 0.120 |
Why?
|
Oxidative Stress | 2 | 2016 | 3139 | 0.120 |
Why?
|
Vitreous Body | 1 | 2016 | 401 | 0.120 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2017 | 354 | 0.110 |
Why?
|
Age of Onset | 1 | 2021 | 3344 | 0.110 |
Why?
|
Granuloma | 1 | 2016 | 329 | 0.110 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12986 | 0.110 |
Why?
|
Basketball | 1 | 2013 | 45 | 0.100 |
Why?
|
Microscopy, Confocal | 1 | 2019 | 1969 | 0.100 |
Why?
|
Incidental Findings | 1 | 2017 | 698 | 0.100 |
Why?
|
Interleukin-8 | 1 | 2015 | 704 | 0.100 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21178 | 0.090 |
Why?
|
Syndrome | 1 | 2017 | 3271 | 0.090 |
Why?
|
Daptomycin | 1 | 2011 | 71 | 0.090 |
Why?
|
Staphylococcus epidermidis | 1 | 2011 | 121 | 0.090 |
Why?
|
Optic Nerve Diseases | 1 | 2014 | 342 | 0.090 |
Why?
|
Vancomycin Resistance | 1 | 2011 | 125 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 12250 | 0.090 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1089 | 0.090 |
Why?
|
Drug Substitution | 1 | 2013 | 292 | 0.090 |
Why?
|
Inflammasomes | 1 | 2015 | 540 | 0.090 |
Why?
|
Sarcoidosis | 1 | 2016 | 535 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2019 | 3511 | 0.090 |
Why?
|
DNA, Mitochondrial | 1 | 2015 | 872 | 0.080 |
Why?
|
Lipids | 2 | 2018 | 3322 | 0.080 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 661 | 0.080 |
Why?
|
Blast Injuries | 1 | 2013 | 319 | 0.080 |
Why?
|
Young Adult | 5 | 2022 | 59980 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8535 | 0.080 |
Why?
|
Endophthalmitis | 1 | 2011 | 263 | 0.080 |
Why?
|
Massachusetts | 1 | 2021 | 8890 | 0.080 |
Why?
|
Eye Infections, Bacterial | 1 | 2011 | 239 | 0.080 |
Why?
|
Boston | 1 | 2021 | 9360 | 0.070 |
Why?
|
Prognosis | 2 | 2020 | 29963 | 0.070 |
Why?
|
Fibrinolytic Agents | 1 | 2016 | 2079 | 0.070 |
Why?
|
Time Factors | 2 | 2021 | 40154 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10622 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2022 | 3275 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2021 | 65295 | 0.060 |
Why?
|
Software | 1 | 2019 | 4472 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2015 | 3227 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3449 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2420 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 1 | 2013 | 3738 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15424 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2016 | 5141 | 0.060 |
Why?
|
Cognition | 1 | 2021 | 7059 | 0.050 |
Why?
|
Schizophrenia | 1 | 2022 | 6977 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11923 | 0.050 |
Why?
|
Phenotype | 1 | 2021 | 16718 | 0.050 |
Why?
|
Staphylococcal Infections | 1 | 2011 | 1396 | 0.050 |
Why?
|
Clinical Competence | 1 | 2017 | 4859 | 0.050 |
Why?
|
Rabbits | 2 | 2020 | 4751 | 0.040 |
Why?
|
MicroRNAs | 1 | 2016 | 3792 | 0.040 |
Why?
|
Portugal | 1 | 2020 | 91 | 0.040 |
Why?
|
Apolipoprotein E2 | 1 | 2019 | 134 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 18063 | 0.040 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2020 | 222 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2019 | 3684 | 0.040 |
Why?
|
Densitometry | 1 | 2018 | 151 | 0.040 |
Why?
|
Area Under Curve | 1 | 2021 | 1639 | 0.040 |
Why?
|
Tonometry, Ocular | 1 | 2018 | 238 | 0.030 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.030 |
Why?
|
Ophthalmoscopy | 1 | 2017 | 172 | 0.030 |
Why?
|
Bruch Membrane | 1 | 2016 | 65 | 0.030 |
Why?
|
Sensory Thresholds | 1 | 2017 | 377 | 0.030 |
Why?
|
Tissue Adhesions | 1 | 2016 | 222 | 0.030 |
Why?
|
Vision, Low | 1 | 2017 | 162 | 0.030 |
Why?
|
Homozygote | 1 | 2019 | 1774 | 0.030 |
Why?
|
Cornea | 1 | 2022 | 1316 | 0.030 |
Why?
|
Aneurysm | 1 | 2018 | 343 | 0.030 |
Why?
|
Amyloid | 1 | 2019 | 849 | 0.030 |
Why?
|
Motor Skills | 1 | 2017 | 521 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 596 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2017 | 771 | 0.030 |
Why?
|
Explosions | 1 | 2013 | 106 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 7469 | 0.030 |
Why?
|
Energy Intake | 1 | 2020 | 2145 | 0.020 |
Why?
|
Dietary Fats | 1 | 2020 | 2001 | 0.020 |
Why?
|
Pedigree | 1 | 2019 | 4539 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2016 | 1168 | 0.020 |
Why?
|
Chronic Disease | 2 | 2018 | 9362 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2201 | 0.020 |
Why?
|
Adolescent | 2 | 2015 | 89046 | 0.020 |
Why?
|
Antioxidants | 1 | 2016 | 1671 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18330 | 0.020 |
Why?
|
Child | 1 | 2015 | 80771 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6331 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2783 | 0.020 |
Why?
|
Life Style | 1 | 2018 | 3931 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5750 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2018 | 4045 | 0.020 |
Why?
|
Cataract | 1 | 2011 | 837 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14766 | 0.010 |
Why?
|
Cohort Studies | 2 | 2017 | 41718 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13284 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10582 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6310 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2015 | 4925 | 0.010 |
Why?
|
Diet | 1 | 2020 | 8089 | 0.010 |
Why?
|
Cell Line | 1 | 2015 | 15567 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8504 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 13048 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15925 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10748 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20169 | 0.010 |
Why?
|
Internship and Residency | 1 | 2017 | 5947 | 0.010 |
Why?
|
Animals | 2 | 2020 | 168965 | 0.010 |
Why?
|
Brain | 1 | 2019 | 27163 | 0.010 |
Why?
|
United States | 1 | 2020 | 72971 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36582 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 74886 | 0.010 |
Why?
|